Reduction of drug resistance through calcium control in epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) resistant lung cancer cells

S. Yang (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea), S. Kim (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea)

Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1648
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Yang (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea), S. Kim (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea). Reduction of drug resistance through calcium control in epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) resistant lung cancer cells. 1648

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: